ID: ALA1161329

Max Phase: Preclinical

Molecular Formula: C12H19NO

Molecular Weight: 193.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)(C)NCC(O)c1ccccc1

Standard InChI:  InChI=1S/C12H19NO/c1-12(2,3)13-9-11(14)10-7-5-4-6-8-10/h4-8,11,13-14H,9H2,1-3H3

Standard InChI Key:  NRVOOKOHYKJCPB-UHFFFAOYSA-N

Associated Targets(non-human)

Beta-2 adrenergic receptor 182 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 193.29Molecular Weight (Monoisotopic): 193.1467AlogP: 2.11#Rotatable Bonds: 3
Polar Surface Area: 32.26Molecular Species: BASEHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.70CX LogP: 1.96CX LogD: -0.30
Aromatic Rings: 1Heavy Atoms: 14QED Weighted: 0.77Np Likeness Score: -0.19

References

1. IJzerman AP, Bultsma T, Timmerman H..  (1986)  Quantitative evaluation of the beta 2-adrenoceptor intrinsic activity of N-tert-butylphenylethanolamines.,  29  (4): [PMID:2870189] [10.1021/jm00154a020]

Source